Hepatocelluar carcinoma associated with attenuated familial adenomatous polyposis: A case report and review of the literature

Clinical Colorectal Cancer

Volumn 11, Issue 1, 2012, Pages 77-81

  Li, Mingqing ^a   Gerber, David A ^b   Koruda, Mark ^b   O'Neil, Bert H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Familial adenomatosis polyposis; Hepatocelluar carcinoma

Indexed keywords

ALANINE; ANTINEOPLASTIC AGENT; APC PROTEIN; BETA CATENIN; DOXORUBICIN; GLYCINE; SORAFENIB; WNT PROTEIN;

ABDOMINAL PAIN; ADULT; BLOOD ANALYSIS; CANCER SCREENING; CASE REPORT; CHEMOEMBOLIZATION; CHINA; COLON RESECTION; COLONOSCOPY; COLORECTAL SURGERY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA SEQUENCE; ESOPHAGOGASTRODUODENOSCOPY; EXON; FAMILIAL COLON POLYPOSIS; FEMALE; GENE MUTATION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILEOPROCTOSTOMY; JAUNDICE; LABORATORY TEST; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SEROLOGY; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPTOM; TUMOR VOLUME; WEIGHT REDUCTION;

EID: 84861553757     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2011.05.007     Document Type: Article

References (29)

1. Chargelaigue A: Des polypes du rectum [Polyps of the rectum]. Thesis Paris, 1859 [in French]. Available at: http://www.med.upenn.edu/gastro/ documents/MedClinNAcolonicpolyps.pdf.
2. Harned RK, Buck JL, Olmsted WW, et al. Extracolonic manifestations of the familial adenomatous polyposis syndromes. AJR Am J Roentgenol 1991; 156:481-5.
3. Su LK, Abdalla EK, Law CH, et al. Biallelic inactivation of the APC gene is associated with hepatocellular carcinoma in familial adenomatous polyposis coli. Cancer 2001; 92:332-9.
4. Gruner BA, DeNapoli TS, Andrews W, et al. Hepatocellular carcinoma in children associated with Gardner syndrome or familial adenomatous polyposis. J Pediatr Hematol Oncol 1998; 20:274-8.
5. Lagarde A, Rouleau E, Ferrari A, et al. Germline APC mutation spectrum derived from 863 genomic variations identified through a 15-year medical genetics service to French patients with FAP. J Med Genet 2010; 47:721-2.
6. Brosens LA, Keller JJ, Offerhaus GJ, et al. Prevention and management of duodenal polyps in familial adenomatous polyposis. Gut 2005; 54:1034-43.
7. Mihalatos M, Apessos A, Dauwerse H, et al. Rare mutations predisposing to familial adenomatous polyposis in Greek FAP patients. BMC Cancer 2005; 5:40.
8. Tao H, Shinmura K, Yamada H, et al. Identification of 5 novel germline APC mutations and characterization of clinical phenotypes in Japanese patients with classical and attenuated familial adenomatous polyposis. BMC Res Notes 2010; 3:305.
9. Filipe B, Baltazar C, Albuquerque C, et al. APC or MUTYH mutations account for the majority of clinically well-characterized families with FAP and AFAP phenotype and patients with more than 30 adenomas. Clin Genet 2009; 76:242-55.
10. Veale A. Intestinal Polyposis. Eugenics Laboratory Memoir Series 40. New York: Cambridge University Press; 1965.
11. Laferla G, Kaye SB, Crean GP: Hepatocellular and gastric carcinoma associated with familial polyposis coli. J Surg Oncol 1988; 38:19-21.
12. Spigelman AD, Farmer KC, James M, et al. Tumours of the liver, bile ducts, pancreas and duodenum in a single patient with familial adenomatous polyposis. Br J Surg 1991; 78:979-80.
13. Van Steenbergen W, Fevery J, De Groote J, et al. Hepatocellular carcinoma in a case of familial polyposis coli. Am J Gastroenterol 1989; 84:1120-1.
14. Weinberger JM, Cohen Z, Berk T. Polyposis coli preceded by hepatocellular carcinoma: report of a case. Dis Colon Rectum 1981; 24:296-300.
15. Zeze F, Ohsato K, Mitani H, et al. Hepatocellular carcinoma associated with familial polyposis of the colon. Report of case. Dis Colon Rectum 1983; 26:465-8.
16. Peifer M, Polakis P. Wnt signaling in oncogenesis and embryogenesis-a look outside the nucleus. Science 2000; 287:1606-9.
17. Su LK, Vogelstein B, Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science 1993; 262:1734-7.
18. Tickenbrock L, Kossmeier K, Rehmann H, et al. Differences between the interaction of beta-catenin with non-phosphorylated and single-mimicked phosphorylated 20-amino acid residue repeats of the APC protein. J Mol Biol 2003; 327:359-67.
19. The Wnt homepage. Wnt Target Genes. Available at: http://www.stanford. edu/group/nusselab/cgi-bin/wnt/target-genes. Accessed June 8, 2011.
20. Wong CM, Fan ST, Ng IO. beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer 2001; 92: 136-45.
21. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 2003; 1653:1-24.
22. Albuquerque C, Breukel C, van der Luijt R, et al. The "just-right" signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. Hum Mol Genet 2002; 11:1549-60.
23. Moisio AL, Jarvinen H, Peltomaki P. Genetic and clinical characterisation of familial adenomatous polyposis: a population based study. Gut 2002; 50:845-50.
24. Liu H, Ye L, Wang QW, et al. Effect of a conserved peptide derived from Kunitz domain of hepatitis B virus x protein on the cell cycle and apoptosis of HepG2 cells via the proteasome pathway. Chin Med J (Engl) 2009; 122:460-5.
25. Longato L, de la Monte S, Kuzushita N, et al. Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver. Hepatology 2009; 49:1935-43.
26. Han SH, Reddy KR, Keeffe EB, et al. Clinical outcomes of liver transplantation for HBV-related hepatocellular carcinoma: data from the NIH HBV OLT study. Clin Transplant 2011; 25:E152-62.
27. Schlitt HJ, Mornex F, Shaked A, et al. Immunosuppression and hepatocellular carcinoma. Liver Transpl. [Epub ahead of print]. DOI: 10.1002/lt.22318. 2011.
28. Yokoyama I, Carr B, Saitsu H, et al. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 1991; 68:2095-100.
29. Manicassamy S, Reizis B, Ravindran R, et al. Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science 2010; 329:849-53.